As of 2025-09-18, the Relative Valuation of PTC Therapeutics Inc (PTCT) is 130.29 USD. This relative valuation is based on P/E multiples. With the latest stock price at 60.65 USD, the upside of PTC Therapeutics Inc based on Relative Valuation is 114.8%.
The range of the Relative Valuation is 100.27 - 162.20 USD.
| Range | Selected | |
| Trailing P/E multiples | 12.7x - 19.2x | 16.2x |
| Forward P/E multiples | 14.0x - 20.5x | 16.8x |
| Fair Price | 100.27 - 162.20 | 130.29 |
| Upside | 65.3% - 167.4% | 114.8% |
| Date | P/E |
| 2025-09-16 | 7.54 |
| 2025-09-15 | 7.45 |
| 2025-09-12 | 7.71 |
| 2025-09-11 | 7.70 |
| 2025-09-10 | 7.36 |
| 2025-09-09 | 7.38 |
| 2025-09-08 | 7.19 |
| 2025-09-05 | 7.23 |
| 2025-09-04 | 7.32 |
| 2025-09-03 | 7.01 |
| 2025-09-02 | 6.62 |
| 2025-08-29 | 6.23 |
| 2025-08-28 | 6.29 |
| 2025-08-27 | 6.29 |
| 2025-08-26 | 6.24 |
| 2025-08-25 | 6.22 |
| 2025-08-22 | 6.39 |
| 2025-08-21 | 6.18 |
| 2025-08-20 | 6.17 |
| 2025-08-19 | 6.26 |
| 2025-08-18 | 6.29 |
| 2025-08-15 | 6.16 |
| 2025-08-14 | 6.15 |
| 2025-08-13 | 6.08 |
| 2025-08-12 | 5.72 |
| 2025-08-11 | 5.47 |
| 2025-08-08 | 5.73 |
| 2025-08-07 | 6.36 |
| 2025-08-06 | 6.48 |
| 2025-08-05 | 6.45 |
| 2025-08-04 | 6.60 |
| 2025-08-01 | 6.58 |
| 2025-07-31 | 6.58 |
| 2025-07-30 | 6.43 |
| 2025-07-29 | 6.22 |
| 2025-07-28 | 5.60 |
| 2025-07-25 | 5.65 |
| 2025-07-24 | 5.85 |
| 2025-07-23 | 5.94 |
| 2025-07-22 | 5.86 |
| 2025-07-21 | 6.04 |
| 2025-07-18 | 6.01 |
| 2025-07-17 | 6.13 |
| 2025-07-16 | 6.08 |
| 2025-07-15 | 6.03 |
| 2025-07-14 | 6.24 |
| 2025-07-11 | 6.13 |
| 2025-07-10 | 6.25 |
| 2025-07-09 | 6.15 |
| 2025-07-08 | 6.02 |